From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes

During the last decade we experienced a surge in the number of glucose lowering agents that can be used to treat patients with type 2 diabetes. Especially important are the discoveries that sodium glucose co-transporter type 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosenzon, Ofri, Del Prato, Stefano, Schechter, Meir, Leiter, Lawrence A., Ceriello, Antonio, DeFronzo, Ralph A., Raz, Itamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082901/
https://www.ncbi.nlm.nih.gov/pubmed/33910583
http://dx.doi.org/10.1186/s12933-021-01281-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082901/
https://www.ncbi.nlm.nih.gov/pubmed/33910583
http://dx.doi.org/10.1186/s12933-021-01281-y

Ejemplares similares